2020 annual financial data
CytomX Therapeutics, Inc. 2020 Operating margin
CytomX Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -117.7%.
Operating income was -80,540,000 USD and net income was -64,819,999 USD.
Operating cash flow was 5,259,000 USD.
Get free CytomX Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 68,427,000 USD
- Operating income
- -80,540,000 USD
- Net income
- -64,819,999 USD
- Operating cash flow
- 5,259,000 USD